Hepatitis Australia monitors for news articles which have relevance to hepatitis B or hepatitis C in Australia. From time-to-time we also issue public statements and media releases which will also be shared here.
The World Hepatitis Summit 2022 will review progress and renew commitments by global partners to accelerate action to achieve the global target of eliminating of viral hepatitis by 2030. Read more
Hepatitis Australia looks forward to working with the new Australian Government to eliminate hepatitis B and hepatitis C. Read more
The Australian Government can take seven important actions in the next 12 months to pursue elimination by 2030 Read more
Hepatitis Australia is recruiting for three positions across its policy and program teams. Hepatitis Australia offers remote working from any location within Australia as well as generous salary sacrificing arrangements to increase take home pay. Read more
Towards the end of the 46th Parliament, people from across Australia came together for a momentous hepatitis B event. You can watch the event here. Read more
The 13th Australasian Viral Hepatitis Conference 29 May - 31 May 2022. Read more
The HepBcommunity.org Research Showcase is a new online space for researchers and people impacted by hepatitis B to share and collaborate. You can win $100 and $250 prizes by sharing and participating. Read more
The issue of multi-country severe acute (non-viral) hepatitis in children is attracting interest and media coverage. Hepatitis Australia understands media approaches have been made to Member organisations for comment. Read more
Following great success over the last two years, Hepatitis Australia will be holding the Third National Hepatitis Elimination Forum on 23 and 24 November 2022. We encourage all state and territory hepatitis organisation staff to block out these dates in your calendars. Read more
The third WIPCVH will now be held 22-24 June, 2022 in Saskatoon, Canada. A dynamic program for the conference is under development. Early bird registrations and abstract submissions are open. Read more
Can a simple hashtag allow us to listen, engage and evaluate Australia’s hepatitis elimination knowledge and actions? Read more
The purpose of this brief is to provide the viral hepatitis community and sector workforce with an update on telehealth for hepatitis B and hepatitis C. Read more
Hepatitis Australia is seeking an evaluation expert to develop a Monitoring and Evaluation Framework for ongoing implementation by the organisation. Read more
Hepatitis Australia is seeking applications from a person interested in joining the Hepatitis Australia Board as a Community Board Member to be appointed at the 2021 Annual General Meeting for a two-year term. Read more
Hepatitis Australia is seeking a highly skilled policy and research analyst with a commitment to social justice and public health. Read more
For World Hepatitis Day 2021 Australia adopted the global theme of Hep Can’t Wait! In this article we highlight some of the activities that took place in Australia and through our global partners. Read more
In the lead up to World Hepatitis Day on 28 July, Hepatitis Australia is collaborating with many other Australian organisations, research institutes and professional bodies to provide invaluable insights into hepatitis B and hepatitis C in Australia. Find out how you can help. Read more
The Parliamentary Friends Group for Action of Blood Borne Viruses Co-Chairs, Tim Wilson, MP and Senator Louise Pratt invite you to a Parliamentary Morning Tea on Thursday 12 November. Read more
The Australian Injecting and Illicit Drug Users League (AIVL) and Hepatitis Australia are highlighting international calls for Needle and Syringe Programs (NSPs) in prisons, along with a greater focus on harm reduction initiatives, ahead of International Drug Users Day on 1 November. Read more
6 October 2020 - Hepatitis Australia welcomes the Australian Government’s commitment to diverse hepatitis research, however we remain concerned that the 2019 Health Budget funding for hepatitis commitments is yet to hit the ground. Read more
6 October 2020 - Hepatitis Australia welcomes the Australian Government’s significant investment of $230 million to expand the listing of Tecentriq® and Avastin® (atezolizumab and bevacizumab) on the Pharmaceutical Benefits Scheme (PBS). Read more
6 October 2020 - Hepatitis Australia is celebrating the news that the Nobel Prize in Physiology or Medicine 2020 has been awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice ‘for the discovery of Hepatitis C virus’. Read more
Patient safety and continuity of care is extremely important, particularly for people who have chronic and complex diseases or conditions, which is why Hepatitis Australia has joined the Continuity of Care Collaboration Read more
22 September 2020: Hepatology Nurse Practitioner, Tracey Jones, has become the first Australian nurse to be awarded the Associate Fellow designation from the American Association for the Study of Liver Diseases Read more